Cancer Research UK logo.
SearchDonate
  • Search

A study looking at INCB106385 for advanced solid cancers

Overview

Cancer types:

Anal cancer, Bladder cancer, Bowel (colorectal) cancer, Breast cancer, Head and neck cancers, Kidney cancer, Laryngeal cancer, Liver cancer, Lung cancer, Mouth and oropharyngeal cancer, Non small cell lung cancer (NSCLC), Ovarian cancer, Pancreatic cancer, Pharyngeal cancer, Prostate cancer, Renal cell cancer, Stomach cancer

Status:

Closed

Phase:

Phase 1

Details

This study is looking at a drug called INCB106385 by itself or with another drug called retifanlimab (INCMGA00012) for some solid cancers. It is open to people with cancer that has spread to another part of the body or the nearby tissue (advanced cancer).

A is any cancer apart from blood cancers such as leukaemia and lymphoma.

Recruitment start: 13 June 2022

Recruitment end: 18 April 2023

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Rebecca Kristeleit

Supported by

Incyte Corporation

Last reviewed: 17 May 2023

CRUK internal database number: 18043

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.